Evidence map›Paper›PMID 7616056›Full record

ReviewImmunologic research1994

Gamma 2b transgenic mice as a model for the role of immunoglobulins in B cell development.

U Storb, P Roth, B K Kurtz

Abstract readReview
PubMed Publisher
In one paragraph

Review in Immunologic research, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

U StorbDepartment of Molecular Genetics and Cell Biology, University of Chicago, Ill., USA.
P Roth
B K Kurtz
University of Chicago · US

Funding

CONTROL OF IMMUNOGLOBULIN SYNTHESISR37AI024780 · NIAID · UNIVERSITY OF CHICAGO · PI STORB, URSULA B · 1992 to 2001
$430k
EXPRESSION OF IMMUNOGLOBULIN GENES IN TRANSGENIC MICER01HD023089 · NICHD · UNIVERSITY OF CHICAGO · PI STORB, URSULA B · 1986 to 2000
$275k
CONTROL OF IMMUNOGLOBULIN SYNTHESISR01AI024780 · NIAID · UNIVERSITY OF CHICAGO · PI STORB, URSULA B · 1986 to 1990
–
NIAID NIH HHS AI24780NICHD NIH HHS HD23089
6 · The paper itself

Abstract

The development of B lymphocytes is tightly linked to the expression of immunoglobulins (Igs). Pro/preB cells which do not correctly rearrange heavy/light chain genes are aborted. Correctly rearranged Ig transgenes are apparently recognized by the developing B cells and can prevent the rearrangement of endogenous Ig genes. Both mu and gamma 2b heavy chain genes cause this feedback inhibition of heavy chain gene rearrangement. Mu transgenes can in addition replace endogenous MU in its preB cell survival/maturation function. However, several different transgenic lines have shown that gamma 2b transgenes do not provide the nurturing functions of mu, except for one unique gamma 2b transgenic line, the C line. In this line mature B cells express gamma 2b only. Presumably, an unknown gene has been activated at the transgene integration site whose product overcomes the need for mu. The function of this gene depends of the presence of the surrogate light chain (sL), and thus must operate in combination with the preB cell receptor or in a downstream signaling/antiapoptosis event requiring the gamma 2b/sL receptor. The analysis of the two types of gamma 2b transgenic mice shows that the signals for preB cell development are highly complex and promises to reveal new insights into the molecular and cellular mechanisms of B cell maturation.

Indexed as

AnimalsB-LymphocytesCell DifferentiationGene Expression Regulation, DevelopmentalGene Rearrangement, B-Lymphocyte, Heavy ChainHematopoietic Stem CellsImmunoglobulinsImmunoglobulin Switch RegionMiceMice, TransgenicSignal TransductionImmunoglobulins

Identifiers

PMID7616056
OpenAlexW2027261024

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.